Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION vs BUTENAFINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPROPION vs BUTENAFINE: Safety Overview

Metric BUPROPION BUTENAFINE
Total FAERS Reports 35,634 768
Deaths Reported 8,577 0
Death Rate 24.1% N/A
Hospitalizations 10,246 4
Average Patient Age 44.6 yrs 59.8 yrs
% Female Patients 70.7% 46.9%
FDA Approval Date Apr 12, 2017 Dec 7, 2001
Manufacturer NuCare Pharmaceuticals, Inc. Kroger Company
Route ORAL TOPICAL
Marketing Status Discontinued Discontinued